Update on use of aldesleukin for treatment of high-risk metastatic melanoma
Rodabe N Amaria,1 Alexandre Reuben,2 Zachary A Cooper,2,3 Jennifer A Wargo2,3 1Department of Melanoma Medical Oncology, 2Department of Surgical Oncology, 3Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: High-dose interleukin-2 has been used...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/update-on-use-of-aldesleukin-for-treatment-of-high-risk-metastatic-mel-peer-reviewed-article-ITT |